PAPER
Synthesis of 5-Perfluoroalkyl-2,3-dihydro-1,4-diazepines
2309
5-(3-Chloro-1,1,2,2,3,3-hexafluoropropyl)-2,3-dihydro-1H-
[1,4]diazepine (2b)5
Mp 104–105 °C.
19F NMR (acetone-d6): = –56.9 (s).
MS (EI): m/z (%) = 256 (M+, 46.94), 255 (M+ – 1, 100.00), 221 (M+
– Cl, 20.46).
IR (KBr): 3226, 3068, 2993, 2913, 1631, 1556, 1320, 1178, 1120,
1095, 967, 794, 757 cm–1.
1H NMR (acetone-d6): = 7.19 (br, 1 H, NH), 7.01 (d, 1 H,
Anal. Calcd for C12H11ClF2N2: C, 56.25; H, 4.29; N, 10.94; F,
14.84. Found: C, 56.02; H, 4.29;, N, 10.79; F, 14.78.
JHH = 9.0 Hz), 5.01 (d, 1 H, JHH = 9.0 Hz), 4.14 (s, 2 H), 3.55 (s, 2
5-Heptafluoropropyl-7-butyl-2,3-dihydro-1H-[1,4]diazepine
H).
(2h)
Mp 73–75 °C.
19F NMR (acetone-d6): = –69.3 (t, 2 F), –113.6 (m, 2 F), –120.9
(m, 2 F).
IR (KBr): 3235, 3113, 2940, 1613, 1589, 1543, 1442, 1350, 1229,
1114, 783, 748 cm–1.
1H NMR (CDCl3): = 4.91 (s, 1 H), 4.02 (s, 2 H), 3.36 (s, 2 H), 2.19
(t, 2 H, J = 7.2 Hz), 1.53 (m, 2 H), 1.36 (m, 2 H), 0.94 (t, 3 H, J =
7.2 Hz).
19F NMR (CDCl3): = –80.6 (t, 3 F), –115.8 (m, 2 F), –126.4 (m, 2
F).
5-(Chlorodifluoromethyl)-2,3-dihydro-1H-[1,4]diazepine (2c)5
Mp 135–136 °C.
IR (KBr): 3232, 3067, 2993, 2908, 1623, 1560, 1465, 1448, 1315,
1199, 1086, 896, 757 cm–1.
1H NMR (CDCl3): = 6.69 (d, 1 H, JHH = 9.0 Hz), 5.29 (br, 1 H,
NH), 5.01 (d, 1 H, JHH = 9.0 Hz), 4.06 (s, 2 H), 3.46 (s, 2 H).
MS (EI): m/z (%) = 320 (M+, 36.32), 305 (M+ – CH3, 25.37), 291
19F NMR (CDCl3): = –57.9 (s).
(M+ – C2H5, 65.59), 278 (M+ – C3H6, 100.00).
Anal. Calcd for C12H15F7N2: C, 45.00; H, 4.69; N, 8.75; F, 41.56.
Found: C, 45.00; H, 4.81; N, 8.61; F, 41.48.
5-Undecafluoropentyl-2,3-dihydro-1H-[1,4]diazepine (2d)5
Mp 85–86 °C.
IR (KBr): 3224, 3069, 2993, 1633, 1558, 1467, 1318, 1278, 1108,
963, 807, 763, 736 cm–1.
5-(3-Chloro-1,1,2,2,3,3-hexafluoropropyl)-7-butyl -2,3-dihy-
dro-1H-[1,4]diazepine (2i)
Mp 53–55 °C.
1H NMR (acetone-d6): = 7.17 (br, 1 H, NH), 7.02 (d, 1 H,
J
H).
HH = 9.0 Hz), 5.02 (d, 1 H, JHH = 9.0 Hz), 4.14 (s, 2 H), 3.54 (s, 2
IR (KBr): 3230, 3096, 2962, 2875, 1612, 1591, 1541, 1340, 1194,
1114, 778 cm–1.
19F NMR (acetone-d6): = –81.7 (t, 3 F), –113.4 (m, 2 F), –121.9
(m, 2 F), –122.5 (m, 2 F), –126.8 (m, 2 F).
1H NMR (CDCl3): = 4.93 (s, 1 H), 4.03 (s, 2 H), 3.37 (s, 2 H), 2.20
(t, 2 H, J = 7.5 Hz), 1.55 (m, 2 H), 1.38 (m, 2 H), 0.94 (t, 3 H, J =
7.5 Hz).
5-Heptafluoropropyl-7-phenyl-2,3-dihydro-1H-[1,4]diazepine
19F NMR (CDCl3): = –67.1 (t, 2 F), –114.1 (m, 2 F), –120.3 (m, 2
F).
(2e)7
Mp 75–76 °C.
MS (EI): m/z (%) = 338 (M+ + 2, 9.87), 336 (M+, 29.54), 321 (M+ –
IR (KBr): 3232, 3086, 2980, 1613, 1568, 1536, 1493, 1453, 1353,
1230, 1177, 890, 744, 697 cm–1.
1H NMR (CDCl3): = 7.52–7.41 (m, 5 H), 5.32 (s, 2 H, C=CH,
NH), 4.12 (s, 2 H), 3.51 (s, 2 H).
CH3, 27.03), 307 (M+ – C2H5, 68.29), 294 (M+ – C3H6, 100.00).
Anal. Calcd for C12H15ClF6N2: C, 42.79; H, 4.46; N, 8.32; F, 33.88.
Found: C, 42.87; H, 4.48; N, 8.12; F, 33.97.
19F NMR (CDCl3): = –80.4 (t, 3 F), –115.3 (m, 2 F), –126.1 (m, 2
F).
5-Chlorodifluoromethyl-7-butyl-2,3-dihydro-1H-[1,4]diaz-
epine (2j)
Mp 58–60 °C.
5-(3-Chloro-1,1,2,2,3,3-hexafluoropropyl)-7-phenyl-2,3-dihy-
dro-1H-[1,4]diazepine (2f)
Mp 83–84 °C.
IR (KBr): 3218, 3103, 2967, 2860, 1614, 1587, 1542, 1338, 1133,
936, 851, 764 cm–1.
1H NMR (CDCl3): = 4.95 (s, 1 H), 3.99 (s, 2 H), 3.40 (s, 2 H), 2.21
(t, 2 H, J = 7.2 Hz), 1.56 (m, 2 H), 1.35 (m, 2 H), 0.94 (t, 3 H, J =
7.2 Hz).
IR (KBr): 3226, 3095, 2988, 1617, 1587, 1540, 1458, 1335, 1193,
1174, 821, 790, 757 cm–1.
1H NMR (CDCl3): = 7.54–7.40 (m, 5 H), 5.34 (s, 1 H), 5.26 (br, 1
H, NH), 4.14 (s, 2 H), 3.53 (s, 2 H).
19F NMR (CDCl3): = –66.7 (t, 2 F), –113.4 (m, 2 F), –119.9 (m, 2
F).
MS (EI): m/z (%) = 356 (M+, 17.75), 355 (M+ – 1, 100.00), 321 (M+
19F NMR (CDCl3): = –57.8 (s).
MS (EI): m/z (%) = 238 (M+ + 2, 11.84), 236 (M+, 36.11), 221 (M+
– CH3, 25.83), 207 (M+ – C2H5, 69.24), 194 (M+ – C3H6, 100.00).
Anal. Calcd for C10H15ClF2N2: C, 50.74; H, 6.34; N, 11.84; F,
16.07. Found: C, 51.20; H, 6.38; N, 11.59; F, 16.09.
– Cl, 7.80).
Anal. Calcd for C14H11ClF6N2: C, 47.12; H, 3.08; N, 7.86; Cl, 9.96;
F, 31.98. Found: C, 47.12; H, 2.87; N, 7.74; Cl, 10.27; F, 31.63.
2-Methyl-5-undecafluoropentyl-2,3-dihydro-1H-[1,4]diazepine
(3a)
Mp 85–87 °C.
5-Chlorodifluoromethyl-7-phenyl-2,3-dihydro-1H-[1,4]diaz-
epine (2g)
Mp 163–164 °C.
IR (KBr): 3223, 3070, 2993, 2900, 1627, 1551, 1242, 1198, 1141,
1058, 954, 846, 736 cm–1.
1H NMR (CDCl3): = 6.61 (d, 1 H, JHH = 8.7 Hz), 5.00 (d, 1 H,
IR (KBr): 3219, 2990, 1608, 1576, 1532, 1492, 1446, 1337, 1185,
1145, 1112, 1033, 908, 762 cm–1.
1H NMR (acetone-d6): = 7.77–7.26 (m, 5 H), 7.26 (br, 1 H, NH),
JHH = 8.7 Hz), 5.20–4.60 (br, 1 H, NH), 4.12 (m, 1 H), 3.80–3.40
(m, 2 H), 1.25 (d, 3 H, JHH = 6.9 Hz).
19F NMR (CDCl3): = –81.2 (t, 3 F), –115.2 (m, 2 F), –122.1 (m, 2
F), –122.7 (m, 2 F), –126.5 (m, 2 F).
5.38 (s, 1 H), 4.16 (s, 2 H), 3.67 (s, 2 H).
Synthesis 2003, No. 15, 2307–2310 © Thieme Stuttgart · New York